Dry eye disease has seen a disturbingly increasing prevalence in recent times.One of the components of this disorder is meibomian gland dysfunction,which results from the blockage of oil secreting glands present in the eyelids.This in turn results in faster evaporation of tears from the surface of the eye,resulting in ocular surface dryness. Thankfully, help is at hand. IRPL therapy aims to not only relieve blocked glands, but has also been proven to regenerate lost meibomian cells, thereby reducing ocular inflammation and reducing the symptoms of dry eye. The treatment is quick, painless and offers instant relief over the course of 3-4 sittings performed a few weeks apart.